Position in DNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,014,945
+$1,966,436 QoQ
Shares Held
405,141
+21.2% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 183 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. DNA ranks #181 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in DNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,014,945 | 405,141 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,048,509 | 334,178 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,603,315 | 313,275 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,745,904 | 325,508 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,588,107 | 318,943 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $576,417 | 101,126 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $931,680 | 94,876 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $693,441 | 85,085 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,973,026 | 5,907,267 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $6,921,248 | 5,966,595 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,386,216 | 6,145,691 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $10,769,467 | 5,949,983 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,972,145 | 5,361,369 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,868,277 | 4,412,240 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,924,819 | 4,097,527 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,653,229 | 3,093,984 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,918,782 | 3,327,220 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,047,680 | 1,996,943 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,050,183 | 2,051,767 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||